These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 1184595)

  • 21. Induction of adult-like antibody, Th1, and CTL responses to measles hemagglutinin by early life murine immunization with an attenuated vaccinia-derived NYVAC(K1L) viral vector.
    Kovarik J; Gaillard M; Martinez X; Bozzotti P; Lambert PH; Wild TF; Siegrist CA
    Virology; 2001 Jun; 285(1):12-20. PubMed ID: 11414801
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Measles immunization: new recommendation.
    Krugman S
    JAMA; 1977 Jan; 237(4):366. PubMed ID: 576171
    [No Abstract]   [Full Text] [Related]  

  • 23. A long-term follow-up study on the efficacy of further attenuated live measles vaccine, Biken CAM vaccine.
    Isomura S; Morishima T; Nishikawa K; Hanada N; Rahman M; Terashima M; Kido S; Ueda S; Takahashi M
    Biken J; 1986 Mar; 29(1):19-26. PubMed ID: 3778422
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Revaccination against measles--a pilot study.
    Watson GI; Nichols JA; Robshaw JR
    J R Coll Gen Pract; 1975 Dec; 25(161):863-73. PubMed ID: 1223275
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [IMMUNIZATION AGAINST MEASLES; ATTENUATED VIRUS VACCINES VERSUS INACTIVATED VIRUS VACCINES].
    VERONESI R
    Pediatr Prat; 1964; 35():141-8. PubMed ID: 14239134
    [No Abstract]   [Full Text] [Related]  

  • 26. [Measles immunization and its problems].
    Kökkaya A
    Mikrobiyol Bul; 1982 Jan; 16(1):66-70. PubMed ID: 7144618
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expanded programme on immunization. Vaccine efficacy in a measles immunization programme.
    Wkly Epidemiol Rec; 1992 Jul; 67(30):224-7. PubMed ID: 1498025
    [No Abstract]   [Full Text] [Related]  

  • 28. [Field trial of combined measles and rubella live attenuated vaccine].
    Takeuchi Y; Togashi T; Sunakawa K; Katou T; Kamiya H; Nakayama T
    Kansenshogaku Zasshi; 2002 Jan; 76(1):56-62. PubMed ID: 11852475
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serological survey for rubella and measles antibodies among first graders.
    Schiff GM; Linnemann CC; Shea L; Witte JJ; Ackerman JH; Stapleton L; Elsea WR; Agna M
    JAMA; 1974 Jan; 227(1):49-52. PubMed ID: 4859626
    [No Abstract]   [Full Text] [Related]  

  • 30. [Means of improving measles vaccinal prophylaxis].
    Smorodintsev AA; Boĭchuk LM; Rykushin IuP; Smorodintsev AA
    Tr Inst Im Pastera; 1979; 53():12-9. PubMed ID: 162456
    [No Abstract]   [Full Text] [Related]  

  • 31. Antibodies to measles virus surface polypeptides in an immunized student population before and after booster vaccination.
    Mäkelä MJ; Marusyk RG; Norrby E; Tyrrell DL; Salmi AA
    Vaccine; 1989 Dec; 7(6):541-5. PubMed ID: 2692335
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Immunization of healthy children with measles-mumps-rubella trivalent vaccine simultaneously given with varicella vaccine].
    Takayama N; Kidokoro M; Suzuki K; Morita M
    Kansenshogaku Zasshi; 1992 Jun; 66(6):776-80. PubMed ID: 1331262
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serological and epidemiological effects and influence factors of primary immunization with current live attenuated measles vaccine (Hu191) among infants aged 6-15 months.
    Youwang Y; Ping W; Feng C
    Vaccine; 2001 Feb; 19(15-16):1998-2005. PubMed ID: 11228370
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Observational study on immune response to yellow fever and measles vaccines in 9 to 15-month old children. Is it necessary to wait 4 weeks between two live attenuated vaccines?
    Michel R; Berger F; Ravelonarivo J; Dussart P; Dia M; Nacher M; Rogier S; Moua D; Sarr FD; Diop OM; Sall AA; Baril L
    Vaccine; 2015 May; 33(20):2301-6. PubMed ID: 25843268
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vaccination of infants in their first year of life with split inactivated measles vaccine incorporated in a diphtheriapertussis-tetanus-polio (inactivated) vaccine (DPTP-M), compared with live measles vaccination.
    Brouwer R
    J Biol Stand; 1976; 4(1):13-23. PubMed ID: 943399
    [No Abstract]   [Full Text] [Related]  

  • 36. Guillain-Barré syndrome following administration of live measles vaccine.
    Grose C; Spigland I
    Am J Med; 1976 Mar; 60(3):441-3. PubMed ID: 1258890
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Measles vaccine: a 27-year follow-up.
    Ramsay ME; Moffatt D; O'Connor M
    Epidemiol Infect; 1994 Apr; 112(2):409-12. PubMed ID: 8150015
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Age of measles immunization in tropics.
    Mirchamsy H; Shafyi A; Mahinpour M; Nazari P
    Dev Biol Stand; 1978; 41():191-4. PubMed ID: 572788
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of the immunogenicity and safety of measles vaccine administered alone or with live, attenuated Japanese encephalitis SA 14-14-2 vaccine in Philippine infants.
    Gatchalian S; Yao Y; Zhou B; Zhang L; Yoksan S; Kelly K; Neuzil KM; Yaïch M; Jacobson J
    Vaccine; 2008 Apr; 26(18):2234-41. PubMed ID: 18394765
    [TBL] [Abstract][Full Text] [Related]  

  • 40. FURTHER OBSERVATIONS ON IMMUNIZATION WITH LIVE ATTENUATED MEASLES VIRUS VACCINE BY INHALATION.
    OKUNO Y
    Arch Gesamte Virusforsch; 1965; 16():294-9. PubMed ID: 14322881
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.